Free Access
Issue
Med Sci (Paris)
Volume 38, Number 4, Avril 2022
Page(s) 381 - 386
Section Repères
DOI https://doi.org/10.1051/medsci/2022042
Published online 29 April 2022
  1. McGorry, Keshavan M, Goldstone S, et al. Biomarkers and clinical staging in psychiatry. World Psychiatry 2014; 13 : 211–23. [CrossRef] [PubMed] [Google Scholar]
  2. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010 ; 67 : 241–251. [CrossRef] [PubMed] [Google Scholar]
  3. National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington, D.C. : National Academies Press, 2011. [Google Scholar]
  4. Fernandes BS, Williams LM, Steiner J, et al. The new field of ‘precision psychiatry’. BMC Medicine 2017 ; 15 : 80. [CrossRef] [PubMed] [Google Scholar]
  5. McGorry PD, Hickie IB. Clinical Staging in Psychiatry. Cambridge: University Press, 2019, 301 p. [Google Scholar]
  6. Tabb K. Should Psychiatry Be Precise? Reduction, Big Data, and Nosological Revision in Mental Health Research. In K. Kendler, J. Parnas, & P. Zachar (Eds.), Levels of Analysis in Psychopathology: Cross-Disciplinary Perspectives. Cambridge: Cambridge University Press, 2020 : pp. 308–34. [CrossRef] [Google Scholar]
  7. Roffman JL. Reaffirming Core Scientific Values in Psychiatry Research. Harv Rev Psychiatry 2019 ; 27 : 275–278. [CrossRef] [PubMed] [Google Scholar]
  8. Joly PB. Le régime des promesses technoscientifique. Sciences et technologies émergentes: pourquoi tant de promesses ? Paris : Hermann, Éditeurs des Sciences et des Arts, 2015. [Google Scholar]
  9. Faucher L. Goyer S [The Research Domain Criteria (Rdoc), reductionism and clinical psychiatry]. Rev Synth 2016 ; 137 : 117–149. [CrossRef] [PubMed] [Google Scholar]
  10. Harris HW, Schaffner KF. Molecular genetics, reductionism, and disease concepts in psychiatry. J Med Philos 1992 ; 17 : 127–153. [CrossRef] [PubMed] [Google Scholar]
  11. Borsboom D, Cramer AOJ, Kalis A. Brain disorders? Not really: Why network structures block reductionism in psychopathology research. Behavioral and Brain Sciences 2019; 42. [Google Scholar]
  12. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell 2000 ; 100 : 57–70. [CrossRef] [PubMed] [Google Scholar]
  13. Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med 2016 ; 374 : 2209–2221. [CrossRef] [PubMed] [Google Scholar]
  14. Prasad V, Fojo T, Brada M. Precision oncology: origins, optimism, and potential. Lancet Oncol 2016 ; 17 : e81–e86. [CrossRef] [PubMed] [Google Scholar]
  15. Haslam N.. Kinds of Kinds: A Conceptual Taxonomy of Psychiatric Categories. Philosophy, Psychiatry, & Psychology 2002 ; 9 : 203–217. [CrossRef] [Google Scholar]
  16. Sulmasy DP. Diseases and natural kinds. Theor Med Bioeth 2005 ; 26 : 487–513. [CrossRef] [PubMed] [Google Scholar]
  17. Kendler, Zachar P, Craver C. What kinds of things are psychiatric disorders? Psychological Medicine 2011; 41 : 1143–50. [CrossRef] [PubMed] [Google Scholar]
  18. Cooper R. Psychiatry and Philosophy of Science. Londres: Routledge, 2014, 208 p. [Google Scholar]
  19. Douglas H.. Inductive Risk and Values in Science. Philosophy of Science 2000 ; 67 : 559–579. [CrossRef] [Google Scholar]
  20. Huneman P, Lambert G, Silberstein M. Classification, Disease and Evidence: New Essays in the Philosophy of Medicine. Heidelberg: Springer, Netherlands, 2015. [CrossRef] [Google Scholar]
  21. Mino JC, Lefève C. Vivre après un cancer. Paris: Dunod, 2016. [Google Scholar]
  22. Paoletti MP, Orilia F. Philosophical and Scientific Perspectives on Downward Causation. Londres: Taylor & Francis, 2017: 340 p [Google Scholar]
  23. Bertolaso M, Ratti E. Conceptual Challenges in the Theoretical Foundations of Systems Biology. Meth Mol Biol 2018 ; 1702 : 1–13. [CrossRef] [PubMed] [Google Scholar]
  24. Darrason M.. Médecine de précision et médecine des systèmes : La médecine personnalisée se trompe-t-elle de cible ?. Lato Sensu: Revue de la Société de philosophie des sciences 2017 ; 4. [Google Scholar]
  25. Le Tourneau C, Kamal M, Trédan O, et al. Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial. Target Oncol 2012 ; 7 : 253–265. [CrossRef] [PubMed] [Google Scholar]
  26. Lemoine M.. Neither from words, nor from visions: understanding p-medicine from innovative treatments. Lato Sensu: Revue de la Société de philosophie des sciences 2017 ; 4 : 12–23. [CrossRef] [Google Scholar]
  27. Briffault X. Psychiatrie 3.0: Etre soi et ses connexions. Paris : Doin, 2019 : 223 p. [Google Scholar]
  28. Audeh W, Blumencranz L, Kling H, et al. Prospective Validation of a Genomic Assay in Breast Cancer: The 70-gene MammaPrint Assay and the MINDACT Trial. Acta Med Acad 2019 ; 48 : 18–34. [CrossRef] [PubMed] [Google Scholar]
  29. Cardoso F, Veer L J, van’t Bogaerts J, et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med 2016 ; 375 : 717–729. [CrossRef] [PubMed] [Google Scholar]
  30. Bhugra D, Tasman A, Pathare S, et al. The WPA-Lancet Psychiatry Commission on the Future of Psychiatry. Lancet Psychiatry 2017 ; 4 : 775–818. [CrossRef] [PubMed] [Google Scholar]
  31. Ferrante M, Redish AD, Oquendo MA, et al. Computational psychiatry: a report from the 2017 NIMH workshop on opportunities and challenges. Mol Psychiatry 2019 ; 24 : 479–483. [CrossRef] [PubMed] [Google Scholar]
  32. Vasconcellos VF, Colli LM, Awada A, et al. Precision oncology: as much expectations as limitations. Ecancermedicalscience 2018; 12 : ed86. [PubMed] [Google Scholar]
  33. Boniolo G, Campaner R. Complexity and integration. A philosophical analysis of how cancer complexity can be faced in the era of precision medicine. 2019. http://philsci-archive.pitt.edu/id/eprint/16043. [Google Scholar]
  34. Addington J, Heinssen R. Prediction and prevention of psychosis in youth at clinical high risk. Annu Rev Clin Psychol 2012 ; 8 : 269–289. [CrossRef] [PubMed] [Google Scholar]
  35. Casali M. Exploring the boundaries and ontology of Psychiatric Disorders (PDs) using the Homeostatic Property Cluster (HPC) model. Lato Sensu: Revue de la Société de philosophie des sciences 2021; 8 : 15–31. [CrossRef] [Google Scholar]
  36. Welch HG, Schwartz L, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. 1st edition. Boston, Massachsetts : Beacon Press, 2012 : 248 p. [Google Scholar]
  37. Pachoud B.. Se rétablir de troubles psychiatriques : un changement de regard sur le devenir des personnes. L’information psychiatrique 2012 ; 88 : 257–266. [CrossRef] [Google Scholar]
  38. Tourette-Turgis C.. Parcours de vie, rupture de santé : quand se maintenir en vie devient un projet. Vie sociale 2017 ; 18 : 91–104. [CrossRef] [Google Scholar]
  39. Plagnol A, Pachoud B, Granger B. Nouveaux modèles de soins: Une clinique au service de la personne. Préface du Professeur Didier Sicard. Paris : Doin, 2018 : 224 p. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.